The non-synonymous canine SNV associated with glioma in this study has recently been shown to result in approximately 50% decrease in P2RX7 function [49], and non-synonymous SNPs in P2RX7 have been identified in an increasing number of human patients with a variety of conditions including cancer [50]. This evidence concerns the gene P2RX7 and central nervous system cancer.